Back to Wiki
Cagrisema (Cagrilintide + Semaglutide)
BlendOverview
A fixed amylin + GLP-1 combination studied for enhanced appetite suppression and weight management.
Quick Facts
- Commonly Available Vial Sizes
- 5 mg, 10 mg, 20 mg
- Typical Research Dose
- 2,400 – 4,800 mcg (2.4 – 4.8 mg)
- Suggested BAC Water
- 1 mL
- Category
- Blend
Notes
Cagrilintide + Semaglutide 1:1 blend. Available in 5mg, 10mg, 20mg vials | Dosing: Once weekly, 68 weeks (Phase 3); ongoing. Route: Subcutaneous (SC)
Commonly Researched Together
Further Reading
For laboratory and research use only. Not for human consumption or clinical use. Information is provided for reference and does not constitute medical advice.